“We assessed Children’s enterprise profile as very strong characterized by its sound market position as the only dedicated pediatric hospital in the eastern Massachusetts region, broad patient draw both nationally and internationally on the strength of its reputation, research, and specialized medical staff, and moderate Medicaid load compared with some other pediatric hospitals,” said S&P analyst Cynthia Keller.
The ratings agency also affirmed the “AA” rating on the hospital’s long-term series P-1 bonds, M bonds and series N bonds.
The outlook is stable, reflecting S&P’s expectation the hospital’s solid business position will remain above median levels.
More articles on healthcare finance:
11 recent hospital outlook and credit rating actions
Erroneous records cost nearly 10,000 Californians temporary loss of tax subsidies
Pennsylvania to test new payment model for rural hospitals: 8 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
